« Previous
Next »
Experimental Hematology
Volume 34, Issue 8
, Pages 1052-1059
, August 2006
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics
References
- . It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement. Br J Haematol. 2003;122:360–375
- Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845–848
- . How do stem cells find their way home?. Blood. 2005;106:1901–1910
- Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003;102:2728–2730
- Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201:1307–1318
- The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005;106:1867–1874
- Fruehauf S, Seeger T, Bridger G, Calandra G, Goldschmidt H, Ho AD. The CXCR4 antagonist AMD3100 mobilizes a more primitive subset of CD34+ cells than G-CSF [abstract]. Blood (ASH Annual Meeting Abstracts), Nov 2005;106:1969.
- Fruehauf S, Seeger T, Topaly J, et al. The CXCR4-antagonist AMD3100 augments the number of mobilized peripheral blood progenitor cells (PBPC) when added to a G-CSF standard mobilization regime and AMD3100-mobilized PBPC result in rapid hematopoietic reconstitution after autologous transplantation [abstract]. Blood (ASH Annual Meeting Abstracts), Nov 2005;106:1961.
- Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood. 2002;99:2037–2044
- Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood. 2004;104:675–686
- Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue and umbilical cord blood. Exp Hematol. 2005;33:1402–1416
- Hematopoietic progenitor cells and their niche—initial behavioral and genetic alterations leading to asymmetric division. Stem Cells. 2005;23:1180–1191
- Maier P, Fleckenstein K, Li L, et al. Gene therapeutic overexpression of MDR1 differentially regulates genes involved in detoxification and apoptosis and confers radioprotection. Radiat Res. In press.
- . A systematic statistical linear modelling approach to oligonucleotide array experiments. Math Biosci. 2002;176:35–51
- AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood. 2006;107:3772–3778
- Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum Gene Ther. 1996;7:1219–1231
- Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J Cell Physiol. 2002;193:299–318
- . USF/c-Myc enhances, while Yin-Yang 1 suppresses the promoter activity of CXCR4, a coreceptor for HIV-1 entry. J Immunol. 1999;162:5986–5992
- . Functional SDF1 alpha/CXCR4 signaling in the developing spinal cord. J Neurochem. 2005;93:452–462
- . Integration of G-protein coupled receptor signaling pathways for activation of a transcription factor (EGR-3). Genomics Proteomics Bioinformatics. 2003;1:173–179
- Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur J Immunol. 2005;35:2991–3001
PII: S0301-472X(06)00378-X
doi: 10.1016/j.exphem.2006.06.003
© 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Experimental Hematology
Volume 34, Issue 8
, Pages 1052-1059
, August 2006
